What are COVID-19 protein-based vaccines? Protein-based vaccines use the specific parts of the virus that the immune system needs to recognise in order to develop an immune response. They do not ...

Around the world, more than a dozen intranasally delivered COVID-19 vaccines have entered clinical trials, and they run the gamut from adenovirus-vectored genes for viral antigens to recombinant ...

the gene that codes for the surface protein of coronavirus, uh, the so-called spike protein. And that's the way the Ebola virus vaccine is made. That's where the Dengue vaccine is made.

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

“We’ll continue working with the Oxford Vaccine ... protein is produced, and it’s hoped this will prime the immune system to attack COVID-19 if it later infects the body. The recombinant ...

Snopes tried to discredit research as a "rumor" when journalist received early results from conference call between researchers and study participants. Spike still detectable in some participants ...

Moderna's massive COVID-19 vaccine sales and prepayments left ... which could compete with established biologic therapies including recombinant proteins and antibodies, although these are in ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.